title: [Apolipoproteins are better risk markers than conventional lipids].
authors.affiliation: Konung Gustaf V:s forskningsinstitut, Solna, AstraZeneca AB, Södertälje. goran.walldius@astrazeneca.com
authors.forename: Göran
authors.initials: G
authors.lastname: Walldius
authors.forename: Ingar
authors.initials: I
authors.lastname: Holme
authors.forename: Ingmar
authors.initials: I
authors.lastname: Jungner
mesh_terms: D000328:Adult; D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood; D001053:Apolipoproteins / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood; D035843:Biomedical Research; D002318:Cardiovascular Diseases / Q000097:blood*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D001055:Apolipoproteins B; D008055:Lipids